glp 1 alzheimer's disease GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Glucagon-like peptide-1 (GLP-1) receptor agonists

Once-daily liraglutide versus lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomized controlled clinical trial

J Mater Chem B

The implication is that clinicians managing menopausal women on GLP-1 therapies should consider hormonal status not as a separate clinical question but as a variable that directly shapes metabolic treatment outcomes

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: Combined post hoc analysis of the SUSTAIN and PIONEER trials

capsule shell ingredient: hydroxypropylmethylcellulose

Despite exciting mechanistic and theoretical potential in GLP-1s, we lack human evidence at this point that demonstrates curative effects